Vivos Therapeutics Inc

NASDAQ:VVOS   3:41:08 PM EDT
0.79
-0.06 (-7.52%)
Earnings Announcements

Vivos Therapeutics Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q

Published: 08/26/2022 12:35 GMT
Vivos Therapeutics Inc (VVOS) - Vivos Therapeutics Announces Receipt of Notice From Nasdaq Regarding Late Filing of Quarterly Report on Form 10-q.
Vivos Therapeutics Inc - Received Notice From Nasdaq Notifying That Co Was Not in Compliance With Requirements of Nasdaq Listing Rule.
Revenue is expected to be $3.72 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $4.08 Million
Next Quarter EPS Guidance is expected to be -$0.24

More details on our Analysts Page.